Dec. 5 at 7:41 AM
$HROW Biggest risks are gone. Refinancing and their drug porftfolio is now diversified. Their drugs are new and they are best in class -> the drugs are at the start of ramp up -> revenues up hugely in 2 years. Potential competition slows down ramp up but doesnt break the thesis -> you get quite risk free 100% gains in 2 years, likely already in a year!! You can wait SP hitting
$50 and buying then and holding 2 years to get at least 100% profits! easy money
This is my final note from other stuff on HROW board. I will post in future other stuff without ticker. You can check my profile if interested in my posts. But i think i did great work gathering the stuff about PolyPid (
$PYPD). It's incredible setup, never seen before like this. In short:
US partnership deal is coming in 3 months, likely already in 2 months (by January). They had crazy positive ph3 results and postive FED minutes (pre NDA meeting). Next step US partnership and NDA submission. I expect a double in 4 months ⬇️
